LymphomaLymphoma: Symptoms, Types, and Survival RateMedically Reviewed: Amitkumar Mehta, MDLymphoma is a type of blood cancer where the lymphocytes, cells of the lymph nodes, mutate and grow out of control. All ArticlesLymphomaLymphomas: The Latest Treatment NewsWant to know the latest lymphoma treatment news? Julie Vose, MD, MBA, University of Nebraska, provide updates from the 2024 ASH Annual Meeting and Exhibition. LymphomaLymphomas: The Latest Treatment NewsWant to know the latest lymphoma treatment news? Julie Vose, MD, MBA, University of Nebraska, provide updates from the 2024 ASH Annual Meeting and Exhibition. Mantle Cell LymphomaFor MCL, Is a Stem Cell Transplant Necessary?Medically Reviewed: Mayur Narkhede, MDThe EA-4151 study is one of the first studies that looks at whether stem cell transplantation is helpful for patients with mantle cell lymphoma who have had initial treatment. Mantle Cell LymphomaFor MCL, Is a Stem Cell Transplant Necessary?Medically Reviewed: Mayur Narkhede, MDThe EA-4151 study is one of the first studies that looks at whether stem cell transplantation is helpful for patients with mantle cell lymphoma who have had initial treatment. Non-Hodgkin LymphomaNew Standard in R/R Follicular Lymphoma?Medically Reviewed: Mayur Narkhede, MDAdding tafasitamab to lenalidomide plus rituximab significantly improves outcomes in patients with relapsed or refractory follicular lymphoma, new data show. Non-Hodgkin LymphomaNew Standard in R/R Follicular Lymphoma?Medically Reviewed: Mayur Narkhede, MDAdding tafasitamab to lenalidomide plus rituximab significantly improves outcomes in patients with relapsed or refractory follicular lymphoma, new data show. LeukemiaWhat Types of Cancer Cause Low Hemoglobin?Medically Reviewed: Pankit Vachhani, MDAny cancer can cause low hemoglobin levels, but some notable associations include blood cancers like leukemia, lymphoma, and myeloma. LeukemiaWhat Types of Cancer Cause Low Hemoglobin?Medically Reviewed: Pankit Vachhani, MDAny cancer can cause low hemoglobin levels, but some notable associations include blood cancers like leukemia, lymphoma, and myeloma. Non-Hodgkin LymphomaPatient Guide to Polivy (Polatuzumab Vedotin-piiq) for DLBCL or HGBLMedically Reviewed: Nina DiPierro, PharmD, BCOPLearn how Polivy is used to treat patients with blood cancers, including diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Non-Hodgkin LymphomaPatient Guide to Polivy (Polatuzumab Vedotin-piiq) for DLBCL or HGBLMedically Reviewed: Nina DiPierro, PharmD, BCOPLearn how Polivy is used to treat patients with blood cancers, including diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Non-Hodgkin LymphomaPatient Guide to Lunsumio (Mosunetuzumab-axgb) for Follicular LymphomaMedically Reviewed: Nina DiPierro, PharmD, BCOPLearn how Lunsumio is used to treat follicular lymphoma that does not respond to other treatments or returns following earlier treatments. Non-Hodgkin LymphomaPatient Guide to Lunsumio (Mosunetuzumab-axgb) for Follicular LymphomaMedically Reviewed: Nina DiPierro, PharmD, BCOPLearn how Lunsumio is used to treat follicular lymphoma that does not respond to other treatments or returns following earlier treatments. Multiple MyelomaDeaths Among Cancer Patients on CAR-T: New DataA recent study explored the underlying cause of nonrelapse deaths among patients treated with CAR-T therapy for lymphoma or multiple myeloma. Multiple MyelomaDeaths Among Cancer Patients on CAR-T: New DataA recent study explored the underlying cause of nonrelapse deaths among patients treated with CAR-T therapy for lymphoma or multiple myeloma. LymphomaBrentuximab & B-Cell Lymphomas: Does It Work?From the ASCO Annual Meeting, Andrew Evens, DO, MSc, FACP, Rutgers Cancer Institute, describes brentuximab vedotin and where it fits in the treatment of b-cell lymphomas. LymphomaBrentuximab & B-Cell Lymphomas: Does It Work?From the ASCO Annual Meeting, Andrew Evens, DO, MSc, FACP, Rutgers Cancer Institute, describes brentuximab vedotin and where it fits in the treatment of b-cell lymphomas. Mantle Cell LymphomaKey Data for Mantle Cell Lymphoma & DLBCLFrom the ASCO Annual Meeting, Andrew Evens, DO, MSc, FACP, Rutgers Cancer Institute, explains study results or mantle cell lymphoma and updates for DLBCL. Mantle Cell LymphomaKey Data for Mantle Cell Lymphoma & DLBCLFrom the ASCO Annual Meeting, Andrew Evens, DO, MSc, FACP, Rutgers Cancer Institute, explains study results or mantle cell lymphoma and updates for DLBCL. LymphomaASCO 2024: ICIs Called “Hugely Impactful”At the 2024 ASCO Annual Meeting, Joshua Brody, MD, explains immune checkpoint inhibitors, how they work, and the likelihood of experiencing adverse events. LymphomaASCO 2024: ICIs Called “Hugely Impactful”At the 2024 ASCO Annual Meeting, Joshua Brody, MD, explains immune checkpoint inhibitors, how they work, and the likelihood of experiencing adverse events. LymphomaASCO 2024: Your Lymphoma UpdateFrom the 2024 ASCO Annual Meeting, Joshua Brody, MD, Mount Sinai, discusses incorporating novel immune therapies earlier and for different types of lymphomas. LymphomaASCO 2024: Your Lymphoma UpdateFrom the 2024 ASCO Annual Meeting, Joshua Brody, MD, Mount Sinai, discusses incorporating novel immune therapies earlier and for different types of lymphomas. LymphomaPatient Guide to Columvi (Glofitamab-gxbm) for DLBCL and LBCLMedically Reviewed: Nina DiPierro, PharmD, BCOPLearn how Columvi is used to treat both diffuse large B-cell lymphoma or large B-cell lymphoma arising from follicular lymphoma that does not respond to other treatments or returns following initial treatment response. LymphomaPatient Guide to Columvi (Glofitamab-gxbm) for DLBCL and LBCLMedically Reviewed: Nina DiPierro, PharmD, BCOPLearn how Columvi is used to treat both diffuse large B-cell lymphoma or large B-cell lymphoma arising from follicular lymphoma that does not respond to other treatments or returns following initial treatment response.
